VBI Vaccines Inc. logo

VBI Vaccines Inc.

NASDAQ:VBIV

Overview | Financials
Company Name VBI Vaccines Inc.
Symbol VBIV
Currency USD
Price 0.065
Market Cap 1,872,954
Dividend Yield 0%
52-week-range 0.013 - 1.35
Industry Biotechnology
Sector Healthcare
CEO Mr. Jeffery R. Baxter FCMA
Website https://www.vbivaccines.com

An error occurred while fetching data.

About VBI Vaccines Inc.

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped

Related Stocks

Zentek Ltd. logo

Zentek Ltd.

ZTEK

1.25 USD

Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc.

VMD

7.33 USD

Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc.

COGT

10.47 USD

KalVista Pharmaceuticals, Inc. logo

KalVista Pharmaceuticals, Inc.

KALV

12.34 USD

MacroGenics, Inc. logo

MacroGenics, Inc.

MGNX

3.25 USD

VistaGen Therapeutics, Inc. logo

VistaGen Therapeutics, Inc.

VTGN

3.25 USD

Prelude Therapeutics Incorporated logo

Prelude Therapeutics Incorporated

PRLD

4.85 USD

bluebird bio, Inc. logo

bluebird bio, Inc.

BLUE

0.529 USD

Singular Genomics Systems, Inc. logo

Singular Genomics Systems, Inc.

OMIC

5.892 USD

The Joint Corp. logo

The Joint Corp.

JYNT

10.87 USD

Financials

Numbers are in millions USD

Numbers are in millions USD